Accesso libero

Do nurses have the switch factor?

Greta Mulders

Greta Mulders

Advanced Nurse Practitioner, Haemophilia Treatment Center, Erasmus University Medical CentreRotterdam, The Netherlands
Profilo Orcid
Cerca questo autore su
Sciendo|Google Scholar
Mulders, Greta
, 
Nanda Uitslager

Nanda Uitslager

Advanced Nurse Practitioner, Van Creveldkliniek, University Medical Center UtrechtUtrecht, The Netherlands
Profilo Orcid
Cerca questo autore su
Sciendo|Google Scholar
Uitslager, Nanda
, 
Sharon Alavian

Sharon Alavian

Former Clinical Nurse Specialist, Hammersmith Hospital Haemophilia Centre, Imperial Healthcare NHS TrustLondon, UK
Cerca questo autore su
Sciendo|Google Scholar
Alavian, Sharon
, 
Anne Wareing

Anne Wareing

Clinical Nurse Specialist, Department of Haemostasis, St George's University Hospital NHS Foundation TrustLondon, UK
Cerca questo autore su
Sciendo|Google Scholar
Wareing, Anne
, 
Kathi Stein Oldenburg

Kathi Stein Oldenburg

Department of Paediatrics, Division of Oncology and Haematology, Charité Universitätsmedizin BerlinGermany
Profilo Orcid
Cerca questo autore su
Sciendo|Google Scholar
Stein Oldenburg, Kathi
 e 
,

,

Cerca questo autore su
Sciendo|Google Scholar
,
  
19 nov 2020
Do nurses have the switch factor?'s Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Scarica la copertina
Categoria dell'articolo: Clinical Practice
Pubblicato online: 19 nov 2020
Pagine: 129 - 135
DOI: https://doi.org/10.17225/jhp00162
Parole chiave
© 2020 Greta Mulders et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
An international survey of haemophilia nurses finds that, while opportunities exist to establish protocol-based best practice, their experience of switching patients’ treatment products is varied.
An international survey of haemophilia nurses finds that, while opportunities exist to establish protocol-based best practice, their experience of switching patients’ treatment products is varied.
Pictured: Visual minutes by WovenInk from the Haemnet Horizons Meeting, London, 2018. The study reported here evolved from the recognition that, while good protocols are available in some HTCs, switching patients to another factor treatment product can be a complex process and there is a need for haemophilia nurses to support each other.
Pictured: Visual minutes by WovenInk from the Haemnet Horizons Meeting, London, 2018. The study reported here evolved from the recognition that, while good protocols are available in some HTCs, switching patients to another factor treatment product can be a complex process and there is a need for haemophilia nurses to support each other.

Summary of questionnaire responses

QUESTIONNUMBER OF RESPONSES (TOTAL=45)
Number of unique nurse responses (from individual centres)45UK10
USA9
Netherlands6
Canada5
New Zealand4
Ireland2
Sweden2
Australia, Croatia, Denmark, Finland, Germany, Romania, Switzerland1 each
NUMBER OF RESPONSES% OF RESPONSES
Ever switched clotting factor product?45Yes4395%
No25%
Reason(s) for switch (more than one answer possible)33*Clinical need34
Funder/purchaser changed product30
Patient request/preference21
Was switch protocol-based?40*Yes2050%
No2050%
If so, who wrote the protocol?24*Haemophilia team1562.5%
Nurse/nurse specialist416.5%
Doctors521%
Frequency of blood tests for pharmacokinetics before switch26*Don’t know14%
No prior testing623%
Blood testing at least once1869%
Depends on product14%
Frequency of blood tests for pharmacokinetics after switch**25*None416%
Depends on product416%
Depends on clinical need14%
No/inappropriate response1664%
Screen for inhibitors before switch?43*Yes3786%
No614%
Was patient association involved?43*Yes1126%
No2763%
Not sure511%
Lingua:
Inglese
Frequenza di pubblicazione:
1 volte all'anno
Argomenti della rivista:
Medicina, Scienze medicali di base, Scienze medicali di base, altro, Medicina clinica, Medicina clinica, altro, Farmacia, Farmacologia
Feed RSS della rivista